MKDCX
Price
$24.73
Change
-$0.17 (-0.68%)
Updated
Feb 21 closing price
Net Assets
4.16B
VEMIX
Price
$29.23
Change
+$0.04 (+0.14%)
Updated
Feb 21 closing price
Net Assets
109.55B
Ad is loading...

MKDCX vs VEMIX

Header iconMKDCX vs VEMIX Comparison
Open Charts MKDCX vs VEMIXBanner chart's image
BlackRock Emerging Mkts K
Price$24.73
Change-$0.17 (-0.68%)
VolumeN/A
Net Assets4.16B
Vanguard Emerging Mkts Stock Idx Instl
Price$29.23
Change+$0.04 (+0.14%)
VolumeN/A
Net Assets109.55B
MKDCX vs VEMIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MKDCX vs. VEMIX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MKDCX is a Buy and VEMIX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VEMIX has more cash in the bank: 110B vs. MKDCX (4.16B). VEMIX pays higher dividends than MKDCX: VEMIX (3.46) vs MKDCX (1.70). MKDCX was incepted earlier than VEMIX: MKDCX (7 years) vs VEMIX (25 years). MKDCX is a more actively managed with annual turnover of: 96.00 vs. VEMIX (5.00). MKDCX (5000000) and VEMIX (5000000) have matching initial minimum investment requirements. VEMIX annual gain was more profitable for investors over the last year : 13.59 vs. MKDCX (4.57). VEMIX return over 5 years is better than : 17.99 vs. MKDCX (2.61).
MKDCXVEMIXMKDCX / VEMIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence7 years25 years-
Gain YTD4.9664.542109%
Front LoadN/AN/A-
Min. Initial Investment50000005000000100%
Min. Initial Investment IRAN/AN/A-
Net Assets4.16B110B4%
Annual Yield % from dividends1.703.4649%
Returns for 1 year4.5713.5934%
Returns for 3 years-10.172.16-470%
Returns for 5 years2.6117.9915%
Returns for 10 yearsN/A31.69-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ABVC0.700.11
+19.59%
ABVC BioPharma
SR75.071.13
+1.53%
Spire
LH249.850.68
+0.27%
Laboratory Corp
CAPL22.87-0.38
-1.63%
CrossAmerica Partners LP
EGAN5.09-0.10
-1.93%
eGain Corp